1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Genetic Testing Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Genetic Testing Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Genetic Testing Services Market Regional Analysis
6.2 North America Genetic Testing Services Market Revenue 2021-2031 (US$ Million)
6.3 North America Genetic Testing Services Market Forecast Analysis
7. North America Genetic Testing Services Market Analysis – by Service Type
7.1 Predictive Testing
- 7.1.1 Overview
- 7.1.2 Predictive Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Carrier Testing
- 7.2.1 Overview
- 7.2.2 Carrier Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Prenatal Testing
- 7.3.1 Overview
- 7.3.2 Prenatal Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Newborn Screening
- 7.4.1 Overview
- 7.4.2 Newborn Screening: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Diagnostic Genetic Testing
- 7.5.1 Overview
- 7.5.2 Diagnostic Genetic Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Genetic Testing Services Market Analysis – by Disease
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Cardiovascular Diseases
- 8.2.1 Overview
- 8.2.2 Cardiovascular Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Metabolic Diseases
- 8.3.1 Overview
- 8.3.2 Metabolic Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Other Diseases
- 8.4.1 Overview
- 8.4.2 Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Genetic Testing Services Market Analysis – by Service Provider
9.1 Hospital-Based Laboratories
- 9.1.1 Overview
- 9.1.2 Hospital-Based Laboratories: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: North America Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Genetic Testing Services Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Genetic Testing Services Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 North America Genetic Testing Services Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 US: North America Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.1.2 US: North America Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.1.3 US: North America Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.2 Canada:
North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Canada: North America Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.2.2 Canada: North America Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.2.3 Canada: North America Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.3 Mexico:
North America Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Mexico: North America Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.3.2 Mexico: North America Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.3.3 Mexico: North America Genetic Testing Services Market Breakdown, by Service Provider
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Eurofins Scientific SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Exact Sciences Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Laboratory Corp of America Holdings
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 23andMe Holding Co
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Ambry Genetics Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Quest Diagnostics Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 NeoGenomics Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Centogene NV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Ancestry Genomics Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Gene By Gene Ltd
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 SIVOTEC BioInformatics LLC
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Progenesis
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Fulgent Genetics, Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 VERITAS INTERCONTINENTAL
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 GeneDx, LLC
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations